MAPK3 and cancer: High concentrations of ERU (30-100 μmol/L) induce apoptosis by reducing the levels of phosphorylated ERK1/2 and upregulating the expression of caspase-3 and caspase-7, thereby inhibiting cancer cell proliferation.